Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Neuroscience Letters|March 31, 1995
Concurrent reduction of inflammation and spinal Fos-LI neurons by systemic diclofenac in the ratJ Buritova, P Honoré, V Chapman, et al.
Neuroscience|August 1, 1995
Cholecystokinin B receptor antagonism enhances the ability of a low dose of morphine to reduce c-Fos expression in the spinal cord of the ratV Chapman, P Honoré, J Buritova, et al.
Neuroreport|July 10, 1995
Carrageenan oedema and spinal Fos-LI neurones are reduced by piroxicam in the ratJ Buritova, P Honoré, V Chapman, et al.
European Journal of Pharmacology|February 5, 1997
The contribution of peripheral bradykinin B2 receptors to carrageenan-evoked oedema and spinal c-Fos expression in ratsJ Buritova, V Chapman, P Honoré, et al.
Brain Research|April 9, 1996
Selective cyclooxygenase-2 inhibition reduces carrageenan oedema and associated spinal c-Fos expression in the ratJ Buritova, V Chapman, P Honoré, et al.
Anesthesiology|July 1, 1996
Concomitant administration of morphine and an N-methyl-D-aspartate receptor antagonist profoundly reduces inflammatory evoked spinal c-Fos expressionP Honoré, V Chapman, J Buritova, et al.
European Journal of Pharmacology|May 6, 1996
Interactions between NMDA- and prostaglandin receptor-mediated events in a model of inflammatory nociceptionJ Buritova, V Chapman, P Honoré, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in ratsP Honore, J Buritova, M C Fournié-Zaluski, et al.
British Journal of Pharmacology|January 22, 2009
Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonistA Newman-Tancredi, J-C Martel, M-B Assié, et al.
Pageof 3